UCR biochemist receives grant to develop novel lead compound to treat breast cancer

[News]

A biochemist at the University of California, Riverside, has received a grant from the Congressionally Directed Medical Research Programs, or CDMRP, of the U.S. Department of Defense to develop a novel lead compound to treat breast cancer, the second most commonly diagnosed cancer among American women.

More... (https://www.news-medical.net/news/20191003/UCR-biochemist-receives-grant-to-develop-novel-lead-compound-to-treat-breast-cancer.aspx)